*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Jefferies has slashed its target price for medical devices maker Smith & Nephew from 1,400p to 1,250p after challenges in China weighed heavily on third-quarter results.
Analysts at Canaccord Genuity lowered their target price on shipbroking services business Braemar from 410. 0p to 380. 0p on Friday following the recently announced increase to the UK Employers National Insurance rate.
BNP Paribas Exane upgraded Schroders on Friday to ‘outperform’ from ‘neutral’ ahead of third-quarter results next week, as it pointed to improving momentum and an attractive valuation.
Analysts at Canaccord Genuity lowered their target price on business-to-business technology firm Nexteq from 200. 0p to 110. 0p on Friday, citing short-term headwinds.
RBC Capital Markets has cut target prices for a number of UK-listed banks after this week's landmark ruling on motor finance commissions, saying that the news brings about an increased level of uncertainty and potential downside for lenders.
Analysts at Canaccord Genuity lowered their target price on business-to-business technology firm Nexteq from 200. 0p to 110. 0p on Friday, citing short-term headwinds.
Citi downgraded its stance on alternative asset fund management group Bridgepoint on Wednesday to 'neutral' as it said there were limited near-term catalysts after the shares have risen 80% over the past year.
Analysts at Berenberg lowered their target price on specialty chemicals business Elementis from 190. 0p to 170. 0p on Wednesday after the group's Q3 results a day earlier.
Citi downgraded its stance on alternative asset fund management group Bridgepoint on Wednesday to ‘neutral’ as it said there are limited near-term catalysts and the shares are up 80% over the past year.
Jefferies downgraded its stance on TI Fluid Systems on Tuesday to 'hold' from 'buy' and cut its target price on the stock from 215. 0p following a takeover proposal from ABC Technologies.
The "explainer" released by Melrose Industries on Monday about its 19 Risk and Revenue Sharing Partnerships (RRSPs) is a "positive development," Citi said in a research note.
